As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
55% of HME respondents say mask selection is the biggest challenge during remote CPAP setups in a recent survey SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback